Skip to main content
PMC home page
Gut logoLink to Gut
. 1991 Oct;32(10):1192–1197. doi: 10.1136/gut.32.10.1192

Antibodies to a trypsin sensitive pancreatic antigen in chronic inflammatory bowel disease: specific markers for a subgroup of patients with Crohn's disease.

F Seibold 1, P Weber 1, H Jenss 1, K H Wiedmann 1
PMCID: PMC1379384  PMID: 1955175

Abstract

The presence of antibodies against pancreatic juice (PAB) in patients with Crohn's disease has recently been reported. In our study sera from 273 patients with inflammatory bowel disease (222 with Crohn's disease, 51 with ulcerative colitis) have been examined for PAB and also for antibodies against gut tissues by means of indirect immunofluorescence. PAB were found in 68 of the 222 patients with Crohn's disease (31%), with titres ranging from 1/10 to 1/1280, and in only two patients with ulcerative colitis (4%), with titres of 1/20. None were found in 198 patients with various chronic inflammatory diseases and healthy control subjects. No differences were found between the PAB positive and negative patients when the following parameters were compared: disease activity (Crohn's disease activity index), involvement of bowel segments, incidence of extraintestinal disease, or treatment with anti-inflammatory drugs. Only seven of the patients with Crohn's disease had a history of pancreatic disease and of these, four had detectable pancreatic antibodies. Longitudinal observations of 40 patients with Crohn's disease showed a stable pattern for PAB, independent of disease activity and treatment. Partial characterisation of the PAB antigen, isolated from pancreatic juice, showed a trypsin sensitive macromolecular protein of more than 10(6) daltons not identical with a panel of defined exocrine pancreatic proteins. By contrast, antibodies against goblet cells (GAB) were found in 13 of 51 patients with ulcerative colitis (29%) and in none of the patients with Crohn's disease or control subjects. PAB were found as a highly specific serological marker for Crohn's disease and GAB for ulcerative colitis, but the relevance of PAB and GAB in the pathogenesis in Crohn's disease remains unclear.

Full text

PDF
1192

Images in this article

1194Figure 1
on p.1194
1194Figure 2
on p.1194

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Altman H. S., Phillips G., Bank S., Klotz H. Pancreatitis associated with duodenal Crohn's disease. Am J Gastroenterol. 1983 Mar;78(3):174–177. [PubMed] [Google Scholar]
  2. Angelini G., Cavallini G., Bovo P., Brocco G., Castagnini A., Lavarini E., Merigo F., Tallon N., Scuro L. A. Pancreatic function in chronic inflammatory bowel disease. Int J Pancreatol. 1988 Mar;3(2-3):185–193. doi: 10.1007/BF02798930. [DOI] [PubMed] [Google Scholar]
  3. BROBERGER O., PERLMANN P. Autoantibodies in human ulcerative colitis. J Exp Med. 1959 Nov 1;110:657–674. doi: 10.1084/jem.110.5.657. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Best W. R., Becktel J. M., Singleton J. W., Kern F., Jr Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology. 1976 Mar;70(3):439–444. [PubMed] [Google Scholar]
  5. Bohe M., Lindström C., Ohlsson K. Immunohistochemical demonstration of pancreatic secretory proteins in human paneth cells. Scand J Gastroenterol Suppl. 1986;126:65–68. doi: 10.3109/00365528609091896. [DOI] [PubMed] [Google Scholar]
  6. CHAPIN L. E., SCUDAMORE H. H., BAGGENSTOSS A. H., BARGEN J. A. Regional enteritis: associated visceral changes. Gastroenterology. 1956 Mar;30(3):404–415. [PubMed] [Google Scholar]
  7. Carlsson H. E., Lagercrantz R., Perlmann P. Immunological studies in ulcerative colitis. VIII. Antibodies to colon antigen in patients with ulcerative colitis, Crohn's disease, and other diseases. Scand J Gastroenterol. 1977;12(6):707–714. doi: 10.3109/00365527709181708. [DOI] [PubMed] [Google Scholar]
  8. Hibi T., Aiso S., Ishikawa M., Watanabe M., Yoshida T., Kobayashi K., Asakura H., Tsuru S., Tsuchiya M. Circulating antibodies to the surface antigens on colon epithelial cells in ulcerative colitis. Clin Exp Immunol. 1983 Oct;54(1):163–168. [PMC free article] [PubMed] [Google Scholar]
  9. KOFFLER D., MINKOWITZ S., ROTHMAN W., GARLOCK J. Immunocytochemical studies in ulcerative colitis and regional ileitis. Am J Pathol. 1962 Dec;41:733–745. [PMC free article] [PubMed] [Google Scholar]
  10. Lankisch P. G., Koop H., Seelig R., Seelig H. P. Antinuclear and pancreatic acinar cell antibodies in pancreatic diseases. Digestion. 1981;21(2):65–68. doi: 10.1159/000198543. [DOI] [PubMed] [Google Scholar]
  11. Legge D. A., Hoffman H. N., 2nd, Carlson H. C. Pancreatitis as a complication of regional enteritis of the duodenum. Gastroenterology. 1971 Dec;61(6):834–837. [PubMed] [Google Scholar]
  12. Lendrum R., Walker G. Serum antibodies in human pancreatic disease. Gut. 1975 May;16(5):365–371. [PMC free article] [PubMed] [Google Scholar]
  13. Malchow H., Ewe K., Brandes J. W., Goebell H., Ehms H., Sommer H., Jesdinsky H. European Cooperative Crohn's Disease Study (ECCDS): results of drug treatment. Gastroenterology. 1984 Feb;86(2):249–266. [PubMed] [Google Scholar]
  14. Marcussen H. Fluorescent anti-colonic and E. coli antibodies in ulcerative colitis. Scand J Gastroenterol. 1978;13(3):277–281. doi: 10.3109/00365527809179820. [DOI] [PubMed] [Google Scholar]
  15. Marcussen H., Nerup J. Fluorescent anti-colon and organ-specific antibodies in ulcerative colitis. Scand J Gastroenterol. 1973;8(1):9–15. [PubMed] [Google Scholar]
  16. McGiven A. R., Ghose T., Nairn R. C. Autoantibodies in ulcerative colitis. Br Med J. 1967 Apr 1;2(5543):19–23. doi: 10.1136/bmj.2.5543.19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Seyrig J. A., Jian R., Modigliani R., Golfain D., Florent C., Messing B., Bitoun A. Idiopathic pancreatitis associated with inflammatory bowel disease. Dig Dis Sci. 1985 Dec;30(12):1121–1126. doi: 10.1007/BF01314044. [DOI] [PubMed] [Google Scholar]
  18. Strober W., James S. P. The immunologic basis of inflammatory bowel disease. J Clin Immunol. 1986 Nov;6(6):415–432. doi: 10.1007/BF00915248. [DOI] [PubMed] [Google Scholar]
  19. Stöcker W., Otte M., Ulrich S., Normann D., Finkbeiner H., Stöcker K., Jantschek G., Scriba P. C. Autoimmunity to pancreatic juice in Crohn's disease. Results of an autoantibody screening in patients with chronic inflammatory bowel disease. Scand J Gastroenterol Suppl. 1987;139:41–52. doi: 10.3109/00365528709089774. [DOI] [PubMed] [Google Scholar]
  20. TRUELOVE S. C., WITTS L. J. Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J. 1955 Oct 29;2(4947):1041–1048. doi: 10.1136/bmj.2.4947.1041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Tabaqchali S., O'Donoghue D. P., Bettelheim K. A. Escherichia coli antibodies in patients with inflammatory bowel disease. Gut. 1978 Feb;19(2):108–113. doi: 10.1136/gut.19.2.108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Zeromski J., Perlmann P., Lagercrantz R., Hammarström S., Gustafsson B. E. Immunological studies in ulcerative colitis. VII. Anti-colon antibodies of different immunoglobulin classes. Clin Exp Immunol. 1970 Oct;7(4):469–475. [PMC free article] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES